Grants Archive

Grant

2026 – 2029

SOdium gLucose co-transporter-2 inhibitors (SGLT2i) to PreVEnt Heart Failure (SOLVE-HF)

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Odutayo A
Co-Investigators: Vaduganathan M, Abdel-Qadir H, Pinto A, Batt S, Vardeny O, Biering-Sorensen T, Ross H, Lee D, Solomon S
Grant Type: Project Grant
Grant Amount: $1,315,801

Grant

2026 – 2029

Long-term temporal trends and projections of stroke incidence, prevalence, and outcomes in Ontario, Canada until 2050 (StrOke2050)

Granting Agency: Canadian Institutes of Health Research
Principal Investigators: Joundi R
Co-Investigators: Austin P, Fleet J, Kapral M, Lee D, Pechlivanoglou P, Sharma M, Smith E, Vyas M, Yu A
Grant Type: Project Grant
Grant Amount: $229,500

Grant

2026 – 2028

Long-term temporal trends and projections of stroke incidence, prevalence, and outcomes in Ontario, Canada until 2050 (StrOke2050)

Granting Agency: AHSC AFP Innovation Fund
Principal Investigators: Joundi R
Co-Investigators: Yu A, Austin P, Fang J, Pechlivanoglou P, Moskalewicz A, Fleet J, Vyas M, Smith E, Sharma M, Lee D
Grant Type: Innovation Fund
Grant Amount: $195,339

Grant

2026 – 2028

Fast or slow stream? Optimizing early recovery models for patients with severe stroke

Granting Agency: StrokeCog
Principal Investigators: Simmonds K
Co-Investigators: Bayley M
Grant Type: New Investigator
Grant Amount: $200,000

Grant

2025 – 2029

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY)

Granting Agency: CIHR-PHSI
Principal Investigators: Abdel-Qadir H, Amir E
Co-Investigators: Aseyev O, Bajwa F, Bhatia RS, Brezden-Masley C, Calvillo Arguelles O, Chan K, Connelly K, Dent S, Doumouras B, Foroutan F, Irish J, Jerzak K, Lee R, Mittal A, Nadler M, Osataphan N, Paterson I, Savard M-F, Thavendiranathan P, Tomlinson G, Udell J, Wijeysundera H, Yang E, Yared K, Yu A, Zafar A
Grant Type: Project Grant
Grant Amount: $1,487,925

Grant

2025 – 2029

Examining the capacity of an opinion leader to alter emergency physician practice: Initiating oral anticoagulation for patients with atrial fibrillation

Granting Agency: Heart and Stroke Foundation of Canada
Principal Investigators: Atzema C
Co-Investigators: Abdel-Qadir H, Austin P, Cox J, Dainty K, Ivers N, Jackevicius C, Lee D, Redelmeier D, Savage D, Taljaard M
Grant Type: Operating
Grant Amount: $358,434

Grant

2025 – 2028

Complicated grief among caregivers bereaved from heart failure

Granting Agency: Heart and Stroke Foundation of Canada
Principal Investigators: Bouchard K
Co-Investigators: Isenberg S, Liu P, Hebert P, O’Shea L, McGuinty C, Wells G, Reed J, Moran C
Grant Type: Operating
Grant Amount: $292,819

Grant

2025 – 2027

Plasma exchange use in patients with Multiple Sclerosis (PLUMS)

Granting Agency: Multiple Sclerosis Society of Canada/MS Canada
Principal Investigators: Vyas M
Co-Investigators: Rotstein D, Taghdiri F, Oh J, Pavenski K, Momem A
Grant Type: Catalyst
Grant Amount: $49,999

Grant

2025 – 2026

Association between immigration status and intensity of care of care in patients with stroke

Granting Agency: Physicians' Services Incorporated (PSI)
Principal Investigators: Kuczynski A, Vyas M
Co-Investigators: Kapral M, Yu A, Austin P, Fowler R
Grant Type: Project Grant
Grant Amount: $30,000

Grant

2025 – 2026

Short-term and long-term neurological outcomes of patients visiting the emergency department for double vision

Granting Agency: Physicians' Services Incorporated (PSI)
Principal Investigators: Rastogi A, Vyas M
Co-Investigators: Kapral M, Atzema C, Austin P, Campbell R
Grant Type: Student Project
Grant Amount: $30,000

Grants

Filters

Grant Value

Year Range

ICES Scientists

ICES Site

Research Program

SOdium gLucose co-transporter-2 inhibitors (SGLT2i) to PreVEnt Heart Failure (SOLVE-HF)

Long-term temporal trends and projections of stroke incidence, prevalence, and outcomes in Ontario, Canada until 2050 (StrOke2050)

Long-term temporal trends and projections of stroke incidence, prevalence, and outcomes in Ontario, Canada until 2050 (StrOke2050)

Fast or slow stream? Optimizing early recovery models for patients with severe stroke

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY)

Examining the capacity of an opinion leader to alter emergency physician practice: Initiating oral anticoagulation for patients with atrial fibrillation

Complicated grief among caregivers bereaved from heart failure

Plasma exchange use in patients with Multiple Sclerosis (PLUMS)

Association between immigration status and intensity of care of care in patients with stroke

Short-term and long-term neurological outcomes of patients visiting the emergency department for double vision